PPCB

Propanc Biopharma
PPCB

6 hedge funds and large institutions have $48.7K invested in Propanc Biopharma in 2026 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

more ownership

Funds ownership: →

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

30% less capital invested

Capital invested by funds: $69.5K → $48.7K (-$20.8K)

Holders
6
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$43.4K
2
+$34K
3
+$9.67K
4
SCA
Sassicaia Capital Advisers
New York
+$3.8K
5
MG
Marex Group
+$641

Top Sellers

1
-$13.7K
2
-$8.72K
3
-$2.38K
4
Morgan Stanley
Morgan Stanley
New York
-$1
Name Holding Trade Value Shares
Change 		Change in
Stake
UBS Group
1
UBS Group
Switzerland
$19.4K
Jane Street
2
Jane Street
New York
$15.2K
MG
3
Marex Group
$7.18K
VF
4
Virtu Financial
New York
$4K
SCA
5
Sassicaia Capital Advisers
New York
$1.7K
XT
6
XTX Topco
Cayman Islands
$1.28K
TSS
7
Two Sigma Securities
New York
–
Two Sigma Investments
8
Two Sigma Investments
New York
–
Morgan Stanley
9
Morgan Stanley
New York
–